sur M1 Kliniken AG (ETR:DE000A0S)
M1 Kliniken AG Reports Significant Financial Growth for 2025
Berlin-based M1 Kliniken AG has released its preliminary figures for the 2025 fiscal year, highlighting a substantial growth in EBIT by 29.2% and earnings per share increasing by 40%. Group revenue climbed by 7.4% to EUR 364.3 million, marking continued profitable growth.
The beauty segment exceeded expectations, crossing the EUR 100 million revenue threshold for the first time. This segment saw an 11.2% revenue rise to EUR 102 million, with an EBIT increase of 41.5%. The segment's success is attributed to optimized processes and targeted pricing strategies.
Moreover, M1 Kliniken AG successfully sold HAEMATO Pharm GmbH. This move aims to strengthen its position as a leading provider of medical aesthetics. Looking ahead, the company plans to expand its clinic network and further enhance its market presence internationally.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de M1 Kliniken AG